                         SEQUENCE LISTING

<110>  Shayakhmetov, Dmitry M
       Di Paolo, Nelson C
 
<120>  Detargeted adenovirus variants and related methods

<130>  PCT3MEASY101

<140>  PCT/US16/13765
<141>  2016-01-17

<150>  US 62/105,284
<151>  2015-01-20

<160>  10    

<170>  PatentIn version 3.5

<210>  1
<211>  16
<212>  PRT
<213>  Human Adenovirus Serotype 5

<400>  1

Leu Gly Gly Val Ile Asn Thr Glu Thr Leu Thr Lys Val Lys Pro Lys 
1               5                   10                  15      


<210>  2
<211>  16
<212>  PRT
<213>  Human Adenovirus Serotype 5

<400>  2

Leu Gly Gly Val Ile Asn Thr Glu Ala Leu Thr Lys Val Lys Pro Lys 
1               5                   10                  15      


<210>  3
<211>  61
<212>  PRT
<213>  Artificial

<220>
<223>  Human adenovirus serotype 5 penon chimera with laminin 1 
       insertion

<400>  3

Asn Ala Ala Ala Ser Gly Thr Lys Leu Leu Ile Ser Gln Ala Arg Lys 
1               5                   10                  15      


Gln Ala Ala Ser Ile Lys Val Ala Val Ser Ala Asp Arg Asp Cys Ile 
            20                  25                  30          


Arg Ala Tyr Gln Pro Gln Ile Ser Ser Thr Asn Tyr Asn Thr Leu Thr 
        35                  40                  45              


Gly Ser Thr Gly Gly Ala Lys Pro Gln Lys Lys Pro Val 
    50                  55                  60      


<210>  4
<211>  68
<212>  PRT
<213>  Artificial

<220>
<223>  Human adenovirus serotype 5 penton chimera with human laminin 3

<400>  4

Asn Ala Ala Ala Ser Gly Thr Arg Glu Leu Ile Gln Ala Arg Asp Ala 
1               5                   10                  15      


Ala Ser Lys Val Ala Val Pro Met Arg Phe Asn Gly Lys Ser Gly Val 
            20                  25                  30          


Glu Val Arg Leu Pro Asn Asp Leu Glu Asp Leu Lys Gly Tyr Thr Ser 
        35                  40                  45              


Leu Ser Leu Gly Ser Thr Gly Gly Ala Pro Glu Val Glu Lys Pro Gln 
    50                  55                  60                  


Lys Lys Pro Val 
65              


<210>  5
<211>  14
<212>  PRT
<213>  Artificial

<220>
<223>  Human adenovirus serotype 5 hexon HVR1 mutation 1

<400>  5

Glu Trp Asp Ser Ala Ala Thr Ser Thr Ala Gly Gly Thr His 
1               5                   10                  


<210>  6
<211>  12
<212>  PRT
<213>  Artificial

<220>
<223>  Human adenovirus serotype 5 hexon HVR1 mutation 2

<400>  6

Asp Glu Ala Ala Thr Gly Gly Ser Gly Gln Gln Lys 
1               5                   10          


<210>  7
<211>  6
<212>  PRT
<213>  Artificial

<220>
<223>  Human adenovirus serotype 5 and serotype 41 hexon chimera

<400>  7

Thr Lys Asp Asn Asn Lys 
1               5       


<210>  8
<211>  15
<212>  PRT
<213>  Artificial

<220>
<223>  Human adenovirus serotype 5 and serotype 51 hexon HVR1 chimera

<400>  8

Trp Glu Gln Lys Lys Thr Thr Gly Gly Asn Asp Met Glu Thr His 
1               5                   10                  15  


<210>  9
<211>  15
<212>  PRT
<213>  Artificial

<220>
<223>  Human adenovirus serotype 5 penton chimera 1

<400>  9

Met Gly Ser Gly Cys Asn Gly Gln Gly Glu Gln Cys Ala Ala Ala 
1               5                   10                  15  


<210>  10
<211>  15
<212>  PRT
<213>  Artificial

<220>
<223>  Human adenovirus serotype 5 penton chimera 2

<400>  10

Met Gly Ser Gly Arg Lys Lys Arg Arg Gln Arg Arg Ala Ala Ala 
1               5                   10                  15  


